Mnestic functions were studied in 220 senile patients with neuroses, neurosis-like vascular disorders, endogenous depression, initial vascular psycho-organic syndrome. In senile functional psychic disorders a secondary affect-bound reduction of short-term memory was detected. Dynamic (affect-related) components could be shown as parts of initial vasculogenic psycho-organic syndrome. Relieving these affective disorders and asthenia was conductive to evaluation of the true degree of partially reversible mnestic disorders. Subjective estimates of memory deficit in these patients were inconsistent with actual conditions and correlated with asthenia, affective disorders, somatic state, microsocial environmental impacts. Goal-directed action on these components which are secondary ones in the memory defect structure can promote the treatment efficiency in these patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

psychic disorders
8
psycho-organic syndrome
8
affective disorders
8
disorders
6
[memory changes
4
patients
4
changes patients
4
patients functional
4
functional vascular
4
vascular psychic
4

Similar Publications

Theory of mind in schizophrenia through a clinical liability approach: a sib-pair study.

Front Psychol

December 2024

Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.

Background: Consistent findings indicate that Theory of Mind (ToM) is impaired in schizophrenia (SZ). To investigate whether such deficits are trait- or state-dependent, we investigated if ToM is modified by clinical liability markers (such as basic symptoms and psychotic-like experiences), focusing on the analysis of unaffected siblings of individuals diagnosed with SZ.

Methods: The study included a total of 65 participants: 38 patients diagnosed with a schizophrenia-spectrum disorder and 27 healthy siblings.

View Article and Find Full Text PDF

We aimed to examine the relationship of Dopamine transporter (DAT) and vesicular monoamine transporter (VMAT-2) gene and protein levels with psychic experiences and other clinical parameters in individuals with Methamphetamine Use Disorder (MUD). This study included 50 males diagnosed with MUD and 50 males as a smoking control (SC) and nonsmoking control (NSC). Community Assessment of Psychic Experiences (CAPE) was administered to patients and controls; Addiction Profile Index, Treatment Motivation Questionnaire, and Substance Craving Scale were administered only to the patient group.

View Article and Find Full Text PDF

Introduction: Cognitive biases can be defined as dysfunctional patterns of thought formation that lead to incorrect conclusions and abnormal perceptions and are critical factors in the development and maintenance of psychosis. Two self-report measures assessing cognitive biases in psychosis spectrum disorder (PSD) have recently been developed: the Davos Assessment of Cognitive Biases Scale (DACOBS) and the Cognitive Biases Questionnaire for Psychosis (CBQp). This study aimed to validate the Turkish versions of the DACOBS and CBQp.

View Article and Find Full Text PDF

Background: The article concerns the psychology of trauma: the intensity of the experienced threats and reactions to the trauma in the form of post-traumatic stress disorder (PTSD), defenses and post-traumatic growth (PTG) in Ukrainian immigrants in Poland. The issues of trauma psychology were studied in connection with the relationships with parents.

Participants And Procedure: The methods used mainly concerned the specifics of experiencing strong threats (trauma) and responding to them (PCL-5 questionnaire, Psycho-Social and Psychic Defenses Questionnaire, Post-Traumatic Growth Inventory), determination of closeness to parents (Scale of Closeness to Biological Parents) and secure and non-secure attachment style (Attachment Style Questionnaire).

View Article and Find Full Text PDF

Despite promise of its supplementation as both monotherapy and add-on treatment in autism spectrum disorder (ASD), the biobehavioral effects of Palmitoylethanolamide (PEA) in autistic adults have never been explored so far. We discussed the cases of two autistic adults with different degrees of severity (level 1 and level 2) presenting with symptoms of psychic distress, who were treated with ultramicronized-PEA (um-PEA) 600 mg/day monotherapy for a sustained period of 4 months. The level 1 autistic patient showed improved depressive symptoms and social engagement at a 12-week follow-up, in parallel to a tendency toward reduced inflammatory response and enhanced endocannabinoid (eCB) signaling, partially relapsing after um-PEA discontinuation at four months.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!